Showing results (31-40 of 167) with videos related to
Sort By:
Pageof 17
Brachytherapy|February 25, 2011
Patients' experiences of high-dose-rate brachytherapy boost for prostate cancer using an inpatient protocolGeorge Hruby, James Y Chen, Joseph Bucci, et al.The Medical Journal of Australia|June 4, 2013
Risk assessment to guide prostate cancer screening decisions: a cost-effectiveness analysisAndrew J Martin, Sarah J Lord, Hannah E Verry, et al.Australian Health Review : a Publication of the Australian Hospital Association|April 20, 2018
Community views on factors affecting medicines resource allocation: cross-sectional survey of 3080 adults in AustraliaLesley Chim, Glenn Salkeld, Patrick J Kelly, et al.Clinical Genitourinary Cancer|October 11, 2017
Screen Failure Rates in Contemporary Randomized Clinical Phase II/III Therapeutic Trials in Genitourinary MalignanciesSarah E Wong, Scott A North, Christopher J Sweeney, et al.Annals of Surgical Oncology|October 31, 2019
Preferences for Immunotherapy in Melanoma: A Systematic ReviewAnn Livingstone, Anupriya Agarwal, Martin R Stockler, et al.The Cochrane Database of Systematic Reviews|October 31, 2017
Bisphosphonates and other bone agents for breast cancerBrent O'Carrigan, Matthew Hf Wong, Melina L Willson, et al.Journal of Medical Imaging and Radiation Oncology|June 20, 2014
Factors influencing the use of RT in NSW: a qualitative study exploring consumer and health professional perspectivesPuma Sundaresan, Christopher G Milross, Andrea Smith, et al.Asia-Pacific Journal of Clinical Oncology|October 29, 2019
Survival and cardiac toxicity in patients with HER2-positive, metastatic breast cancer treated with trastuzumab in routine clinical practiceAnuradha Vasista, Luke Ryan, Sayeda Naher, et al.BMC Cancer|September 17, 2021
Physician-patient communication of costs and financial burden of cancer and its treatment: a systematic review of clinical guidelinesAnupriya Agarwal, Ann Livingstone, Deme J Karikios, et al.Current Medical Research and Opinion|July 4, 2024
Estimating survival scenarios in advanced or metastatic gastric and oesophageal adenocarcinoma: a systematic review of randomized-controlled trialsSayeda K Naher, Rebecca Mercieca-Bebber, Derrick Siu, et al.Pageof 17